⬇️ 下载 PDF
红蓝生物

🧬 抗人CD266/TNFRSF12A参考抗体)

Anti-Human CD266/TNFRSF12A Reference Antibody

货号: RB9T37015023
💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
🏷️ 产品编码
RB9T37015023
🧬 中文名称
抗人CD266/TNFRSF12A参考抗体)
📝 英文名称
Anti-Human CD266/TNFRSF12A Reference Antibody
📦 形态
Liquid
🧪 纯度
>95% purity as determined by SDS-PAGE.
🔹 内毒素水平
Please contact the lab for this information.
🔬 应用
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
🧫 表达系统
Mammalian Cells
🔢 登录号
Q9NP84
🔹 宿主种属
Humanized
🔹 克隆性
Monoclonal
🔹 抗体亚型
IgG1-kappa
🔹 纯化方式
Protein A/G purified from cell culture supernatant.
🔹 浓度
3.33mg/ml
🔹 种属反应性
Human
🔹 靶标
FGF-inducible 14, TNFRSF12A, FN14, CD266, TweakR, Fibroblast growth factor-inducible immediate-early response protein 14, Tweak-receptor, Tumor necrosis factor receptor superfamily member 12A
🔹 背景信息
Enavatuzumab (PDL192; ABT-361) is a humanized IgG1 monoclonal antibody targeting the receptor of TNF-like weak inducer of apoptosis (TWEAK). TWEAK (Fn14; TNFRSF12A), the natural ligand of the TWEAK receptor (TweakR), stimulates multiple cellular responses. Enavatuzumab induces tumor growth inhibition through direct TweakR signaling and antibody dependent cell-mediated cytotoxicity (ADCC). Enavatuzumab can actively recruits and activates myeloid effectors to kill tumor cells. Enavatuzumab inhibits the growth of various human TweakR-positive cancer cell lines and xenografts in vitro and in vivo .
• TWEAK/Fn14 signaling in tumors., PMID:28639899
• The TWEAK/Fn14/CD163 axis-implications for metabolic disease., PMID:34542797
• TWEAK/Fn14 axis in respiratory diseases., PMID:32526219
• TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic metabolic rewiring in triple-negative breast cancer., PMID:38965263
• Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges., PMID:32053869
• Role of the TWEAK/Fn14 pathway in autoimmune diseases., PMID:26659091
• TWEAK/Fn14 signaling: a promising target in intervertebral disc degeneration., PMID:26907852
• Controversies in TWEAK-Fn14 signaling in skeletal muscle atrophy and regeneration., PMID:32200423
• Role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in rheumatic diseases., PMID:23106895
• Tumor Necrosis Factor Receptor Mediates Fibroblast Growth Factor-Inducible 14 Signaling., PMID:28934756
🏷️ 别名
PDL192, 1062149-33-0
🧴 储存缓冲液
0.01M PBS, pH 7.4.
❄️ 稳定性和储存
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
⚠️ For research use only. Not suitable for clinical or therapeutic use.